Navigation Links
House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
Date:12/20/2007

Bill assures patients continue to have access to ZEVALIN(R) and other novel

radioimmunotherapies

SEATTLE, Dec. 20 /PRNewswire-FirstCall/ -- New Medicare legislation passed by the House and Senate extends the 2007 reimbursement methodology for radiopharmaceuticals into 2008. The Centers for Medicare and Medicaid Services (CMS) had implemented new hospital outpatient reimbursement rates for 2008 for radiopharmaceuticals like ZEVALIN(R) (Ibritumomab Tiuxetan) below their acquisition costs. The drugs are used to fight relapsed non-Hodgkin's lymphoma, which for some patients can provide additional therapeutic options. The new Medicare legislation will maintain the current methodology for reimbursement of therapeutic radiopharmaceuticals for the first six months of 2008, giving the drugs' manufacturers and CMS time to seek a permanent reimbursement procedure that more accurately reflects hospital costs associated with the therapy.

"We applaud law makers for responding to the concerns of patients and providers regarding these important therapeutic options for treating patients with this deadly disease," said CTI President and CEO James A. Bianco, M.D. "This legislation will maintain the status quo and provide the drug manufacturers the opportunity to work with CMS on developing an equitable methodology for reimbursing therapeutic radiopharmaceuticals."

Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) has signed an agreement to acquire the U.S. marketing, sales and development rights to ZEVALIN from Biogen Idec, Inc., which it expects to close later this month. Until the transaction is closed, ZEVALIN remains a product and trademark of Biogen Idec, Inc.

About ZEVALIN(R)

ZEVALIN(R) (Ib
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
2. The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO
5. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
8. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
9. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., , HOPKINTON, Mass., Dec. 3 /PRNewswir...q: CALP ), a leading provider of tools and servic...today introduced Living Image 4.0 software for IVI...ware drives the more than 800 Caliper IVIS systems...ving Image 4.0 features advanced spectral unmixing...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ -...earch report is available in its catalogue: ,, ..., http://www.reportlinker.com/p0164232/Neurost..., The world neurostimulation market stands enthus...e resultant rise in age-related diseases such as, ...
(Date:12/2/2009)..., , COPENHAGEN, Dec. 2 T...e with BioIsoprene technology, a breakthrough alte...edient in the manufacture of synthetic rubber with..., Denmark, this week. One tire will be on display ...penhagen International Airport throughout December...
(Date:12/2/2009)..., , LELYSTAD, The Netherlands, Decem...erlands based biotechnology company focusing on pr...mmune therapeutics today announced that it,has app...Officer. , Dr. Mol will be responsible fo...all management and strategic direction of the comp...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2
...NY, N.J., Sept. 6 NPS,Pharmaceuticals, Inc. (Nasd...a cash tender offer for any and all of its outstan...ffer will expire at midnight, Eastern Time on,Octo...ich is described,fully in an offer to purchase and... to the receipt of any minimum amount of tenders. ...
...Mass., Sept. 6 Boston Scientific,Corporation (NYS... of,Directors has elected Ray Elliott as a Directo...immer Holdings, Inc.,Previously, he served as Chai...mer from 2001 to 2007 and President of Zimmer sinc...rector experience in medical devices,orthopaedics ...
...and ST. LOUIS, Sept. 6 Resource Optimization &,In...PO) serving St. Louis-,based Sisters of Mercy Heal...bling members to begin purchasing Elekta,s innovat...w.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO ) ... the image-guided,Elekta Synergy(R) for advanced i...
Other Biology Technology:NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 2NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 3NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 4Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 2Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 3Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions 2
(Date:12/3/2009)... upset by a social snubbing? Your genetics, not yo...ong known that opium-like painkillers, called opio... forms of emotional stress. Now, a new study revie...g shows that small genetic differences in the gene...ty of people,s responses to social rejection. , ...
(Date:12/3/2009)...e measured CO2 levels for the past three years in ... inhabited rural area near Valladolid. The results... Peninsula, show that the levels rose "significant...physicists and meteorologists have been trying to ...w these have evolved in the troposphere over vario...
(Date:12/3/2009)...ntists from the U.S. Department of Energy,s (DOE) ..., and the Indian Institute of Science has made a m...e genetic information in DNA that is necessary to ...arch, published in the December 1, 2009 edition of... that many proteins responsible for interacting at...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 1Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 3Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 1Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 2Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 3Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 4Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 5Two New Dakim Sponsored Blogs Help Families Affected by Dementia 50554 1Two New Dakim Sponsored Blogs Help Families Affected by Dementia 50554 2
... The Patagonian Hippidion horse genus and North Am...on the evolutionary tree, according to a new artic... paper, Jaco Weinstock, Alan Cooper, and colleague...s is younger than previously thought and that Amer...ot Asian emigres. Their analysis has also whittled...
... University of Nevada, Reno scientists have ended ...h bark beetles make pheromones: they manufacture t...nts produce and which are often used in perfumes. ... were incapable of making these substances. , "The...romone production," said Gary Blomquist, professor...
... The open-access journal PLoS Biology has been ass...3.9*, which places PLoS Biology among the most hig...n outstanding statistic for a journal less than tw...business model that supports open access to the sc...r of 13.9 places PLoS Biology above such establish...
Other Biology News:Ancient DNA helps clarify the origins of two extinct New World horse species 2Researchers discover key gene involved in bark beetle pheromone production 2The first impact factor for PLoS Biology ?13.9 2
...nomes has allowed the development of the S. enteri...terica Typhimurium (strain LT2) genome consists of...d a plasmid, pSLT (93,939 bp; 107 ORFs). These ORF...ify all putative open reading frames (ORFs) in S. ...
...oductivity and allows you to achieve a higher leve... beyond traditional paper-based weighing processes... *Instruments supported: Control of METTLER... SG, AT, MT, UMT, AB-S, PB-S, PB-L balances *Job ...
.../500 ml: ,Tryptone 5.0 ,Yeast extract 2.5 ,...,Ferric ammonium citrate 0.250 ,IPTG 0.025 ,K...nd is a complete growth medium containing S-Gal (3...tented autoclavable chromogenic substrate for -gal...
...east extract, 5 ,Sodium chloride, 10 ,Agar, 12...IPTG, 0.03 ,-Gal is a patented, water soluble, ...ase. The enzymatic hydrolysis of S-Gal by -galacto...c+ colonies grown in the presence of S-gal are muc...
Biology Products: